South Korea Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2026-2034
South Korea biomarkers market size reached USD 1,930.6 Million in 2025. Looking forward, IMARC Group expects the market to reach USD 5,637.4 Million by 2034, exhibiting a growth rate (CAGR) of 12.27% during ?2026-2034?. The growing integration of omics technologies, such as genomics, proteomics, and metabolomics, rising integration of artificial intelligence (AI) and machine learning (ML), and increasing investments in research and development (R&D) represent some of the key factors driving the market.
Biomarkers encompass a broad range of substances or characteristics that can be objectively evaluated. They comprise diagnostic biomarkers like specific proteins or genetic markers associated with a particular disease, which identify the presence of an ailment or condition. They also consist of prognostic biomarkers, which predict the likely course and outcome of a disease. They include deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and metabolites, providing information about genetic variations, gene expression, and metabolic processes. They help in visualizing physiological and anatomical changes associated with diseases by using advanced imaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. They play essential parts in cellular functions, and alterations in their levels or structure can indicate disease states. Biomarkers facilitate the early detection of diseases, enabling intervention at a stage when treatment is more effective. They play a pivotal role in personalized medicine by allowing healthcare professionals to tailor treatments as per individual requirements. They are integral in drug development, aiding in the identification of potential drug targets, evaluating treatment efficacy, and predicting adverse effects. They contribute to a deeper understanding of disease mechanisms, fostering advancements in basic and translational research. They drive breakthroughs in understanding disease biology, paving the way for innovative therapies and diagnostic tools.
SOUTH KOREA BIOMARKERS MARKET TRENDS:
At present, the increasing integration of omics technologies, such as genomics, proteomics, and metabolomics, represents one of the crucial factors impelling the market growth in South Korea. Advances in these fields are facilitating the identification of a myriad of biomolecules that can serve as precise and specific markers for various diseases. The ability to analyze the molecular profile of an individual allows for more accurate and targeted diagnosis is facilitating the development of personalized medicine strategies in the country. Besides this, the rising prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders, is contributing to the market growth. Biomarkers play a pivotal part in the early detection and monitoring of these conditions, contributing to timely interventions and improved patient outcomes. In addition, the growing integration of artificial intelligence (AI) and machine learning (ML) into biomarker discovery and analysis is offering a favorable market outlook. Apart from this, precision medicine focuses on tailoring medical treatment processes to the individual characteristics of each patient, considering their genetic makeup, lifestyle, and environmental factors. Biomarkers are integral to this approach, as they enable the examination of patients who are likely to respond positively to specific treatments. Additionally, the rising demand for non-invasive biomarkers, driven by the desire to enhance patient compliance, reduce healthcare costs, and improve the overall diagnostic experience, is bolstering the market growth.
SOUTH KOREA BIOMARKERS MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for ?2026-2034?. Our report has categorized the market based on product, type, disease, application, and end user.
Product Insights:
Type Insights:
Disease Insights:
Application Insights:
End User Insights:
Regional Insights:
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea biomarkers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea biomarkers market?
What is the breakup of the South Korea biomarkers market on the basis of product?
What is the breakup of the South Korea biomarkers market on the basis of type?
What is the breakup of the South Korea biomarkers market on the basis of disease?
What is the breakup of the South Korea biomarkers market on the basis of application?
What is the breakup of the South Korea biomarkers market on the basis of end user?
What are the various stages in the value chain of the South Korea biomarkers market?
What are the key driving factors and challenges in the South Korea biomarkers?
What is the structure of the South Korea biomarkers market and who are the key players?
What is the degree of competition in the South Korea biomarkers market?
Biomarkers encompass a broad range of substances or characteristics that can be objectively evaluated. They comprise diagnostic biomarkers like specific proteins or genetic markers associated with a particular disease, which identify the presence of an ailment or condition. They also consist of prognostic biomarkers, which predict the likely course and outcome of a disease. They include deoxyribonucleic acid (DNA), ribonucleic acid (RNA), proteins, and metabolites, providing information about genetic variations, gene expression, and metabolic processes. They help in visualizing physiological and anatomical changes associated with diseases by using advanced imaging techniques, such as magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. They play essential parts in cellular functions, and alterations in their levels or structure can indicate disease states. Biomarkers facilitate the early detection of diseases, enabling intervention at a stage when treatment is more effective. They play a pivotal role in personalized medicine by allowing healthcare professionals to tailor treatments as per individual requirements. They are integral in drug development, aiding in the identification of potential drug targets, evaluating treatment efficacy, and predicting adverse effects. They contribute to a deeper understanding of disease mechanisms, fostering advancements in basic and translational research. They drive breakthroughs in understanding disease biology, paving the way for innovative therapies and diagnostic tools.
SOUTH KOREA BIOMARKERS MARKET TRENDS:
At present, the increasing integration of omics technologies, such as genomics, proteomics, and metabolomics, represents one of the crucial factors impelling the market growth in South Korea. Advances in these fields are facilitating the identification of a myriad of biomolecules that can serve as precise and specific markers for various diseases. The ability to analyze the molecular profile of an individual allows for more accurate and targeted diagnosis is facilitating the development of personalized medicine strategies in the country. Besides this, the rising prevalence of chronic diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders, is contributing to the market growth. Biomarkers play a pivotal part in the early detection and monitoring of these conditions, contributing to timely interventions and improved patient outcomes. In addition, the growing integration of artificial intelligence (AI) and machine learning (ML) into biomarker discovery and analysis is offering a favorable market outlook. Apart from this, precision medicine focuses on tailoring medical treatment processes to the individual characteristics of each patient, considering their genetic makeup, lifestyle, and environmental factors. Biomarkers are integral to this approach, as they enable the examination of patients who are likely to respond positively to specific treatments. Additionally, the rising demand for non-invasive biomarkers, driven by the desire to enhance patient compliance, reduce healthcare costs, and improve the overall diagnostic experience, is bolstering the market growth.
SOUTH KOREA BIOMARKERS MARKET SEGMENTATION:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for ?2026-2034?. Our report has categorized the market based on product, type, disease, application, and end user.
Product Insights:
- Consumables
- Services
- Software
Type Insights:
- Efficacy Biomarkers
- Safety Biomarkers
- Validation Biomarkers
Disease Insights:
- Cancer
- Cardiovascular Disorders
- Neurological Disorders
- Immunological Disorders
- Renal Disorders
- Others
Application Insights:
- Diagnostics
- Drug Discovery and Development
- Personalized Medicine
- Others
End User Insights:
- Pharmaceutical and Biotechnology Companies
- Diagnostic and Research Laboratories
- Hospitals and Specialty Clinics
- Others
Regional Insights:
- Seoul Capital Area
- Yeongnam (Southeastern Region)
- Honam (Southwestern Region)
- Hoseo (Central Region)
- Others
COMPETITIVE LANDSCAPE:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
KEY QUESTIONS ANSWERED IN THIS REPORT
How has the South Korea biomarkers market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the South Korea biomarkers market?
What is the breakup of the South Korea biomarkers market on the basis of product?
What is the breakup of the South Korea biomarkers market on the basis of type?
What is the breakup of the South Korea biomarkers market on the basis of disease?
What is the breakup of the South Korea biomarkers market on the basis of application?
What is the breakup of the South Korea biomarkers market on the basis of end user?
What are the various stages in the value chain of the South Korea biomarkers market?
What are the key driving factors and challenges in the South Korea biomarkers?
What is the structure of the South Korea biomarkers market and who are the key players?
What is the degree of competition in the South Korea biomarkers market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA BIOMARKERS MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA BIOMARKERS MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY PRODUCT
6.1 Consumables
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Services
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 Software
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
7 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY TYPE
7.1 Efficacy Biomarkers
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Safety Biomarkers
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Validation Biomarkers
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
8 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY DISEASE
8.1 Cancer
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Cardiovascular Disorders
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Immunological Disorders
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Renal Disorders
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Forecast (2026-2034)
8.6 Others
8.6.1 Historical and Current Market Trends (2020-2025)
8.6.2 Market Forecast (2026-2034)
9 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY APPLICATION
9.1 Diagnostics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Drug Discovery and Development
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Personalized Medicine
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Forecast (2026-2034)
9.4 Others
9.4.1 Historical and Current Market Trends (2020-2025)
9.4.2 Market Forecast (2026-2034)
10 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Forecast (2026-2034)
10.2 Diagnostic and Research Laboratories
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Forecast (2026-2034)
10.3 Hospitals and Specialty Clinics
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Forecast (2026-2034)
10.4 Others
10.4.1 Historical and Current Market Trends (2020-2025)
10.4.2 Market Forecast (2026-2034)
11 SOUTH KOREA BIOMARKERS MARKET – BREAKUP BY REGION
11.1 Seoul Capital Area
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2020-2025)
11.1.3 Market Breakup by Product
11.1.4 Market Breakup by Type
11.1.5 Market Breakup by Disease
11.1.6 Market Breakup by Application
11.1.7 Market Breakup by End User
11.1.8 Key Players
11.1.9 Market Forecast (2026-2034)
11.2 Yeongnam (Southeastern Region)
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2020-2025)
11.2.3 Market Breakup by Product
11.2.4 Market Breakup by Type
11.2.5 Market Breakup by Disease
11.2.6 Market Breakup by Application
11.2.7 Market Breakup by End User
11.2.8 Key Players
11.2.9 Market Forecast (2026-2034)
11.3 Honam (Southwestern Region)
11.3.1 Overview
11.3.2 Historical and Current Market Trends (2020-2025)
11.3.3 Market Breakup by Product
11.3.4 Market Breakup by Type
11.3.5 Market Breakup by Disease
11.3.6 Market Breakup by Application
11.3.7 Market Breakup by End User
11.3.8 Key Players
11.3.9 Market Forecast (2026-2034)
11.4 Hoseo (Central Region)
11.4.1 Overview
11.4.2 Historical and Current Market Trends (2020-2025)
11.4.3 Market Breakup by Product
11.4.4 Market Breakup by Type
11.4.5 Market Breakup by Disease
11.4.6 Market Breakup by Application
11.4.7 Market Breakup by End User
11.4.8 Key Players
11.4.9 Market Forecast (2026-2034)
11.5 Others
11.5.1 Historical and Current Market Trends (2020-2025)
11.5.2 Market Forecast (2026-2034)
12 SOUTH KOREA BIOMARKERS MARKET – COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant
13 PROFILES OF KEY PLAYERS
13.1 Company A
13.1.1 Business Overview
13.1.2 Services Offered
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Company B
13.2.1 Business Overview
13.2.2 Services Offered
13.2.3 Business Strategies
13.2.4 SWOT Analysis
13.2.5 Major News and Events
13.3 Company C
13.3.1 Business Overview
13.3.2 Services Offered
13.3.3 Business Strategies
13.3.4 SWOT Analysis
13.3.5 Major News and Events
13.4 Company D
13.4.1 Business Overview
13.4.2 Services Offered
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 Company E
13.5.1 Business Overview
13.5.2 Services Offered
13.5.3 Business Strategies
13.5.4 SWOT Analysis
13.5.5 Major News and Events
14 SOUTH KOREA BIOMARKERS MARKET - INDUSTRY ANALYSIS
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 APPENDIX
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 SOUTH KOREA BIOMARKERS MARKET - INTRODUCTION
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 SOUTH KOREA BIOMARKERS MARKET LANDSCAPE
5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)
6 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY PRODUCT
6.1 Consumables
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2020-2025)
6.1.3 Market Forecast (2026-2034)
6.2 Services
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2020-2025)
6.2.3 Market Forecast (2026-2034)
6.3 Software
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2020-2025)
6.3.3 Market Forecast (2026-2034)
7 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY TYPE
7.1 Efficacy Biomarkers
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2020-2025)
7.1.3 Market Forecast (2026-2034)
7.2 Safety Biomarkers
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2020-2025)
7.2.3 Market Forecast (2026-2034)
7.3 Validation Biomarkers
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2020-2025)
7.3.3 Market Forecast (2026-2034)
8 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY DISEASE
8.1 Cancer
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2020-2025)
8.1.3 Market Forecast (2026-2034)
8.2 Cardiovascular Disorders
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2020-2025)
8.2.3 Market Forecast (2026-2034)
8.3 Neurological Disorders
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2020-2025)
8.3.3 Market Forecast (2026-2034)
8.4 Immunological Disorders
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2020-2025)
8.4.3 Market Forecast (2026-2034)
8.5 Renal Disorders
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2020-2025)
8.5.3 Market Forecast (2026-2034)
8.6 Others
8.6.1 Historical and Current Market Trends (2020-2025)
8.6.2 Market Forecast (2026-2034)
9 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY APPLICATION
9.1 Diagnostics
9.1.1 Overview
9.1.2 Historical and Current Market Trends (2020-2025)
9.1.3 Market Forecast (2026-2034)
9.2 Drug Discovery and Development
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2020-2025)
9.2.3 Market Forecast (2026-2034)
9.3 Personalized Medicine
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2020-2025)
9.3.3 Market Forecast (2026-2034)
9.4 Others
9.4.1 Historical and Current Market Trends (2020-2025)
9.4.2 Market Forecast (2026-2034)
10 SOUTH KOREA BIOMARKERS MARKET - BREAKUP BY END USER
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Overview
10.1.2 Historical and Current Market Trends (2020-2025)
10.1.3 Market Forecast (2026-2034)
10.2 Diagnostic and Research Laboratories
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2020-2025)
10.2.3 Market Forecast (2026-2034)
10.3 Hospitals and Specialty Clinics
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2020-2025)
10.3.3 Market Forecast (2026-2034)
10.4 Others
10.4.1 Historical and Current Market Trends (2020-2025)
10.4.2 Market Forecast (2026-2034)
11 SOUTH KOREA BIOMARKERS MARKET – BREAKUP BY REGION
11.1 Seoul Capital Area
11.1.1 Overview
11.1.2 Historical and Current Market Trends (2020-2025)
11.1.3 Market Breakup by Product
11.1.4 Market Breakup by Type
11.1.5 Market Breakup by Disease
11.1.6 Market Breakup by Application
11.1.7 Market Breakup by End User
11.1.8 Key Players
11.1.9 Market Forecast (2026-2034)
11.2 Yeongnam (Southeastern Region)
11.2.1 Overview
11.2.2 Historical and Current Market Trends (2020-2025)
11.2.3 Market Breakup by Product
11.2.4 Market Breakup by Type
11.2.5 Market Breakup by Disease
11.2.6 Market Breakup by Application
11.2.7 Market Breakup by End User
11.2.8 Key Players
11.2.9 Market Forecast (2026-2034)
11.3 Honam (Southwestern Region)
11.3.1 Overview
11.3.2 Historical and Current Market Trends (2020-2025)
11.3.3 Market Breakup by Product
11.3.4 Market Breakup by Type
11.3.5 Market Breakup by Disease
11.3.6 Market Breakup by Application
11.3.7 Market Breakup by End User
11.3.8 Key Players
11.3.9 Market Forecast (2026-2034)
11.4 Hoseo (Central Region)
11.4.1 Overview
11.4.2 Historical and Current Market Trends (2020-2025)
11.4.3 Market Breakup by Product
11.4.4 Market Breakup by Type
11.4.5 Market Breakup by Disease
11.4.6 Market Breakup by Application
11.4.7 Market Breakup by End User
11.4.8 Key Players
11.4.9 Market Forecast (2026-2034)
11.5 Others
11.5.1 Historical and Current Market Trends (2020-2025)
11.5.2 Market Forecast (2026-2034)
12 SOUTH KOREA BIOMARKERS MARKET – COMPETITIVE LANDSCAPE
12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant
13 PROFILES OF KEY PLAYERS
13.1 Company A
13.1.1 Business Overview
13.1.2 Services Offered
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Company B
13.2.1 Business Overview
13.2.2 Services Offered
13.2.3 Business Strategies
13.2.4 SWOT Analysis
13.2.5 Major News and Events
13.3 Company C
13.3.1 Business Overview
13.3.2 Services Offered
13.3.3 Business Strategies
13.3.4 SWOT Analysis
13.3.5 Major News and Events
13.4 Company D
13.4.1 Business Overview
13.4.2 Services Offered
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 Company E
13.5.1 Business Overview
13.5.2 Services Offered
13.5.3 Business Strategies
13.5.4 SWOT Analysis
13.5.5 Major News and Events
14 SOUTH KOREA BIOMARKERS MARKET - INDUSTRY ANALYSIS
14.1 Drivers, Restraints, and Opportunities
14.1.1 Overview
14.1.2 Drivers
14.1.3 Restraints
14.1.4 Opportunities
14.2 Porters Five Forces Analysis
14.2.1 Overview
14.2.2 Bargaining Power of Buyers
14.2.3 Bargaining Power of Suppliers
14.2.4 Degree of Competition
14.2.5 Threat of New Entrants
14.2.6 Threat of Substitutes
14.3 Value Chain Analysis
15 APPENDIX
